RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform
It includes access to Noom's digital longevity companion for behavioral support, at-home health testing to monitor 17 biomarkers for long-term health and personalized GLP-1 microdosing for those who qualify
The major generics are Noveltreat/Sematrinity (Sun Pharma), Obeda/Usema (Dr Reddy's + USV), Semaglyn/Mashema/Alterme (Zydus), Semanext/Livarise (Lupin via Zydus), Semasize/Obesema/Hepaglide (Alkem), GLIPIQ (Glenmark), Sembolic/Semalix (Torrent injectable + oral), Semabest (MSN Labs first integrated made-in-India semaglutide, April 2026 launch), SUNDAE/Semanat/Semafull (Eris/Natco), and Samakind (Mankind)
Many patients achieve their target weight loss at 1.0 to 1.7 mg weekly rather than the maximum approved 2.4 mg
Semaglutide injections are a safe, effective approach to weight loss